Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Type (Droplet Digital PCR, Chip Based Digital PCR, Others), By Component (Systems, Kits and Assays, Reagents and Consumables), By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others), By End User (Academic and Research Institutions, Biotechnology & Phar

Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format

View Details Buy Now 2890 Download Sample Ask for Discount Request Customization

Digital PCR Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Type (Droplet Digital PCR, Chip Based Digital PCR, Others), By Component (Systems, Kits and Assays, Reagents and Consumables), By Application (Oncology, Infectious Diseases, Rare Diseases, Reproductive Genetics, Others), By End User (Academic and Research Institutions, Biotechnology & Phar

According to World Health Organization (WHO), in December 2021, 273 million cases are diagnosed and approximately 5.3 million deaths have been reported, globally, due to COVID-19.

Recent advancements in dPCR technology have led to increased sensitivity and accuracy, enabling the detection of rare genetic variants and low-level pathogens. This has important implications for cancer diagnosis and monitoring, infectious disease detection, and other areas of research.

Growing demand for precision medicine

Digital PCR enables the detection and quantification of rare genetic mutations with high accuracy, which is important for the development of precision medicine. The increasing demand for personalized medicine is expected to drive the demand for digital PCR.

Rising Adoption of Digital PCR Devices

In 2022, a total of 96,091,120 COVID-19 Cases are counted in the United States.


MIR Segment1

Growing adoption of non-invasive prenatal testing

Non-invasive prenatal testing (NIPT) is becoming increasingly popular, as it enables the detection of fetal genetic abnormalities without the need for invasive procedures. Digital PCR is a key technology used in NIPT, and the growing adoption of NIPT is expected to drive the demand for digital PCR.

Rising Fund for Research and Development Activities in the Digital PCR

Due to COVID19 pandemic, an unexpected demand was increased for Digital PCR in the healthcare and research institute sector. The pandemic has played an important role to enhance the digital PCR market growth. Prevalence of infectious diseases like cancer has also increasedwhich accounts for the need for the diagnosis and detection of the disease. For this reason, funding in the research and development sector has also increased. Increased funding for R&D activities that include the use of digital PCR and Chip based PCR for different purposes, is expected to increase its use and open up new opportunities for global market expansion during the forecast period.

Recent Development

  • Launched in 2021 by QIAGEN, this digital PCR system is designed for ultra-sensitive and accurate detection and quantification of target DNA and RNA sequences. It has a high dynamic range and can detect as few as two copies of a target sequence.
  • Launched in 2020 by JN Medsys, this digital PCR system is designed for the detection of SARS-CoV-2 virus in clinical samples. It uses a multiplex digital PCR assay to simultaneously detect two viral genes with high sensitivity and specificity.
  • Launched in 2019 by RainDance Technologies, this digital PCR system is designed for ultra-sensitive detection and quantification of nucleic acid targets. It uses microfluidic droplet technology to partition each sample into millions of droplets, each of which undergoes digital PCR amplification to detect and quantify target molecules.

Download Free Sample Report

Market Segmentation


MIR Regional

In terms of country, the United States region is dominating the overall globe in digital PCR market. According to Worldometer, as of December 26, 2022 around 102,236,095 confirmed COVID-19 cases have been reported in the United States. This can be ascribed to the increasing cost-effective COVID-19 testing technology in the healthcare sector.

Market Players

Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Genetron Holdings Limited, Naveris, Inc., SAGA Diagnostics, Precigenome LLC

Attribute

Details

Base Year

2022

Historic Data

2018 â€“ 2021

Estimated Year

2023

Forecast Period

2024 – 2028

Quantitative Units

Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

By Type

By Component

By Application

By End User

By Region

Regional scope

North America; Europe; Asia Pacific; South America; Middle East & Africa

Country scope

United States; Mexico; Canada; France; Germany; United Kingdom; Italy; Spain; China; India; South Korea; Japan; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE; Egypt; Turkey

Key companies profiled

Bio-Rad Laboratories, Inc., Fluidigm Corporation, F. Hoffmann-La Roche AG, Merck KGaA, QIAGEN N.V., Thermo Fisher Scientific Inc., Genetron Holdings Limited, Naveris, Inc., SAGA Diagnostics, Precigenome LLC

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Table of Content

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

List Tables Figures

To get a detailed Table of content/ Table of Figures/ Methodology Please contact our sales person at ( chris@marketinsightsresearch.com )

FAQ'S

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@marketinsightsresearch.com

Within 24 to 48 hrs.

You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.